The stakes are high for the pharmaceutical industry, with a constant demand for new treatments and drug discoveries. Companies are always working towards developing new treatments or acquiring promising assets. However, the long R&D timelines coupled with high attrition rates make it difficult to accurately assess the probability of success for compounds targeting new disease […]
